JPRN-UMIN000003375
Completed
未知
Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1 - Prospective cohort study of pediatric ALL treated with TCCSG risk stratification TCCSG ALL L09-1603 v1.1
Tokyo Children's Cancer Study Group0 sites400 target enrollmentMarch 26, 2010
ConditionsAcute Lymphoblastic Leukemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute Lymphoblastic Leukemia
- Sponsor
- Tokyo Children's Cancer Study Group
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •secondary leukemia previously treated patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Increasing the survival of children with blood cancer in India using a standard treatment approach.CTRI/2023/12/060828Cancer Institute
Completed
Not Applicable
Prospective observation study of chronic lymphocytic leukemia, hairy cell leukemia and related diseases in Japan (CLLRSG-01)chronic lymphocytic leukemia, hairy cell leukemia and related diseasesJPRN-UMIN000004915Chronic lymphocytic leukemia and related diseases study group (CLLRSG)200
Active, not recruiting
Phase 1
Blood cancer in younger adults (18-59 years)Patients with de novo acute lymphoblastic leukemia of young adults.-GRAALL-2014/B: Ph- B lineage ALL -GRAALL-2014/T et ATRIALL: T-ALL -GRAAPH-2014: ALL Ph+MedDRA version: 20.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-002146-44-BEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,040
Completed
Not Applicable
Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational studyfirst relapsed acute lymphoblastic leukemia in childrenJPRN-UMIN000002026Japanese Peditric Leukemia/Lymphoma Study Group88
Completed
Phase 2
Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).first relapsed acute lymphoblastic leukemia in childrenJPRN-UMIN000002025Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)69